Maryland Gov. Wes Moore: The way to address housing costs is to build more housing
Speakers
Wes Moore
— Governor of Maryland
Summary
Maryland Governor Wes Moore argues that housing affordability should be addressed by increasing housing supply rather than capping prices. He highlights state policies to free up land, encourage transit-oriented development, and add density, and points to life sciences, IT, and aerospace/defense as priority industries. Moore also discusses federal job losses in Maryland, the state's fiscal position, and the direction of the Democratic Party. Market implications include potential support for homebuilders and positive project developments for Samsung Biologics and AstraZeneca in Maryland.
- Governor Wes Moore says the solution to housing costs is building more housing, not price caps.
- Maryland is using state land, transit-oriented development, and density bonuses to boost housing supply.
- Moore identifies life sciences, IT, and aerospace/defense as Maryland's priority industries.
- Samsung Biologics plans its first Maryland manufacturing facility.
- AstraZeneca is making Maryland's largest-ever investment, creating over 2,600 jobs.
- Moore says federal worker layoffs have hit Maryland harder than any other state.
- He discusses balanced budgets, no new tax increases, and Democratic Party direction.
- The interview follows news of institutional housing stocks falling and homebuilder stocks in focus.
Ideas
Build more housing to fix affordability.
Housing affordability is a supply problem, so the solution is to build more housing and increase inventory rather than cap prices. Maryland is using state land, transit-oriented development, and density bonuses to create more homeownership and long-term wealth. This policy push should support homebuilders.
Samsung Biologics builds first Maryland facility.
Samsung Biologics, Korea's largest biotech platform, is building its first manufacturing facility in Maryland. This supports Maryland's life sciences priority and economic diversification, serving as a positive company-specific project development.
AstraZeneca makes largest Maryland investment.
AstraZeneca is making the largest singular investment in Maryland's history, located in Montgomery County and expected to produce over 2,600 jobs. This reinforces the state's life sciences cluster and is a positive project development for the company.
